217 related articles for article (PubMed ID: 32842990)
1. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
2. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
4. Association of SPP1 promoter variants with hip osteoarthritis susceptibility in Chinese population.
Lv C; Li Y; Xu J; Cao H; Li X; Ma B; Ning P; Wang Y; Wang M; Zhu S; Ge Y; Huang S; Jin Y
Gene; 2015 Jun; 564(1):9-13. PubMed ID: 25796600
[TBL] [Abstract][Full Text] [Related]
5. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
[TBL] [Abstract][Full Text] [Related]
6. SPP1 promoter polymorphisms and glioma risk in a Chinese Han population.
Chen J; Wu Q; Lu Y; Xu T; Huang Y; Ribas J; Ni X; Hu G; Huang F; Zhou L; Lu D
J Hum Genet; 2010 Jul; 55(7):456-61. PubMed ID: 20505679
[TBL] [Abstract][Full Text] [Related]
7. Association of vitamin D receptor gene polymorphisms and risk of urolithiasis: results of a genetic epidemiology study and comprehensive meta-analysis.
Amar A; Afzal A; Hussain SA; Hameed A; Khan AR; Shakoor M; Abid A; Khaliq S
Urolithiasis; 2020 Oct; 48(5):385-401. PubMed ID: 31515573
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin gene polymorphisms and susceptibility to urolithiasis in Iraqi children.
Shamran HA; Ali SH; Ali MA; Al-Mayah QS; Jasim EA
Nephrology (Carlton); 2019 Jan; 24(1):17-20. PubMed ID: 29055055
[TBL] [Abstract][Full Text] [Related]
9. Association between IL-1RN VNTR, IL-1β -511 and IL-6 (-174, -572, -597) gene polymorphisms and urolithiasis.
Çoker Gurkan A; Arisan S; Arisan ED; Sönmez NC; Palavan Ünsal N
Urol Int; 2013; 91(2):220-6. PubMed ID: 23363559
[TBL] [Abstract][Full Text] [Related]
10. Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene.
Gazal S; Sacre K; Allanore Y; Teruel M; Goodall AH; ; Tohma S; Alfredsson L; Okada Y; Xie G; Constantin A; Balsa A; Kawasaki A; Nicaise P; Amos C; Rodriguez-Rodriguez L; Chiocchia G; Boileau C; Zhang J; Vittecoq O; Barnetche T; Gonzalez Gay MA; Furukawa H; Cantagrel A; Le Loët X; Sumida T; Hurtado-Nedelec M; Richez C; Chollet-Martin S; Schaeverbeke T; Combe B; Khoryati L; Coustet B; El-Benna J; Siminovitch K; Plenge R; Padyukov L; Martin J; Tsuchiya N; Dieudé P
Ann Rheum Dis; 2015 Mar; 74(3):e19. PubMed ID: 24448344
[TBL] [Abstract][Full Text] [Related]
11. SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease.
Patel YP; Patel SG; Patel SB; Parikh A; Soni S; Srivastava R; Raval C; Raval MA; Nand Pandey S; Ganpule AP; Desai MR
Gene; 2023 May; 863():147264. PubMed ID: 36804854
[TBL] [Abstract][Full Text] [Related]
12. SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum.
Hendig D; Arndt M; Szliska C; Kleesiek K; Götting C
Clin Chem; 2007 May; 53(5):829-36. PubMed ID: 17384004
[TBL] [Abstract][Full Text] [Related]
13. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
[TBL] [Abstract][Full Text] [Related]
14. Genetic Risk Factors for Idiopathic Urolithiasis: A Systematic Review of the Literature and Causal Network Analysis.
Taguchi K; Yasui T; Milliner DS; Hoppe B; Chi T
Eur Urol Focus; 2017 Feb; 3(1):72-81. PubMed ID: 28720371
[TBL] [Abstract][Full Text] [Related]
15. Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.
Li X; Liu K; Pan Y; Zhang J; Lv Q; Hua L; Wang Z; Li J; Yin C
Biomed Res Int; 2015; 2015():315043. PubMed ID: 25785266
[TBL] [Abstract][Full Text] [Related]
16. Association between calcitonin receptor gene polymorphisms and calcium stone urolithiasis: A meta-analysis.
Qin J; Cai Z; Xing J; Duan B; Bai P
Int Braz J Urol; 2019; 45(5):901-909. PubMed ID: 31626518
[TBL] [Abstract][Full Text] [Related]
17. Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients.
Marciano R; D'Annunzio G; Minuto N; Pasquali L; Santamaria A; Di Duca M; Ravazzolo R; Lorini R
Clin Immunol; 2009 Apr; 131(1):84-91. PubMed ID: 19138884
[TBL] [Abstract][Full Text] [Related]
18. SPP1 gene polymorphisms associated with nephrolithiasis in Turkish pediatric patients.
Tekin G; Ertan P; Horasan G; Berdeli A
Urol J; 2012; 9(4):640-7. PubMed ID: 23235966
[TBL] [Abstract][Full Text] [Related]
19. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-1beta gene and receptor antagonist polymorphisms with calcium oxalate urolithiasis.
Mittal RD; Bid HK; Manchanda PK; Kapoor R
J Endourol; 2007 Dec; 21(12):1565-70. PubMed ID: 18186699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
